Skip to main content

Inflammation and Hepatic Encephalopathy

  • Chapter
  • First Online:
Book cover Hepatic Encephalopathy

Abstract

The pivotal role of ammonia in the pathogenesis of HE in acute liver failure is incontrovertible, but in chronic liver disease a consistent correlation between the concentration of ammonia in the blood and the manifest symptoms of HE is not always observed. Over the past decade, we have begun to characterise the important roles of inflammation, infection, and oxidative stress in modulating the pathophysiological effects of ammonia on the astrocyte, the most commonly affected cell neuropathologically. The synergistic role of inflammation and infection in modulating the cerebral effects of ammonia has been demonstrated and a degree of overlap with sepsis-associated encephalopathy has been postulated. Ammonia may “sensitise” the brain to a systemic inflammatory stimulus which results in a response involving proinflammatory and neurotransmitter pathways. Brain microglial activation may also be implicated. Ammonia has also been shown to induce immune dysfunction with the release of reactive oxygen species from neutrophils which contribute to oxidative stress and systemic inflammation. Not only can this exacerbate the cerebral effects of ammonia but it may also make the individual vulnerable to developing infection which will further predispose to the manifestation of covert or overt HE. This chapter explores the current thoughts and evidence base on this area and discusses the role of existing and novel therapies that might be utilised in those predisposed to developing HE.

The authors Shabnam S. Shabbir and Amit Singh Seyan contributed equally to this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nencki M, Pawlow J, Zaleski J. Ueber den ammoniakgehalt des blutes under der organe und die harnstoffbildung bei den saugethieren. Arch Exp Pathol Pharmakol. 1896;37:26–51.

    Google Scholar 

  2. Clemmesen J, Larsen F, Kondrup J, Hansen B, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology. 1999;29:648–53.

    Article  PubMed  CAS  Google Scholar 

  3. Bernal W, Hall C, Karvellas C, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46(6):1844–52.

    Article  PubMed  CAS  Google Scholar 

  4. Ong JP, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003; 114(3): 188–93.

    Article  PubMed  CAS  Google Scholar 

  5. Shawcross D, Sharifi Y, Canavan J, Yeoman A, Abeles R, Taylor N, et al. Infection and systemic inflammation, not ammonia, are associated with grade III/IV hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol. 2011;54(4):640–9.

    Article  PubMed  CAS  Google Scholar 

  6. Arora S, Martin CL, Herbert M. Myth: interpretation of a single ammonia level in patients with chronic liver disease can confirm or rule out hepatic encephalopathy. CJEM. 2006;8(6):433–5.

    PubMed  Google Scholar 

  7. Zieve FJ, Zieve L, Doizaki WM, Gilsdorf RB. Synergism between ammonia and fatty acids in the production of coma: implications for hepatic coma. J Pharmacol Exp Ther. 1974;191(1):10–6.

    PubMed  CAS  Google Scholar 

  8. Wasmuth H, Kunz D, Yagmur E, Timmer-Stranghoner A, Vidacek D, Siewart E, et al. Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysis. J Hepatol. 2005;42:195–201.

    Article  PubMed  CAS  Google Scholar 

  9. Antoniades C, Berry P, Wendon J, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol. 2008;49:845–61.

    Article  PubMed  CAS  Google Scholar 

  10. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990;11(1):49–53.

    Article  PubMed  CAS  Google Scholar 

  11. Jalan R, Pollok A, Shah SH, Madhavan K, Simpson KJ. Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. J Hepatol. 2002;37(4):536–8.

    Article  PubMed  CAS  Google Scholar 

  12. Wright G, Shawcross D, Olde Damink S, Jalan R. Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension. Metab Brain Dis. 2007;22(3–4):375–88.

    Article  PubMed  CAS  Google Scholar 

  13. Rajkovic IA, Williams R. Mechanisms of abnormalities in host defences against bacterial infection in liver disease. Clin Sci (Lond). 1985;68(3):247–53.

    CAS  Google Scholar 

  14. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology. 1986;6(2):252–62.

    Article  PubMed  CAS  Google Scholar 

  15. Mookerjee R, Stadlbauer V, Lidder S, Wright G, Hodges S, Davies N, et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts outcome. Hepatology. 2007;46(3):831–40.

    Article  PubMed  CAS  Google Scholar 

  16. Bode C, Kugler V, Bode J. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 1987;4:8–14.

    Article  PubMed  CAS  Google Scholar 

  17. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med. 1996;125(8):680–7.

    PubMed  CAS  Google Scholar 

  18. Papadopoulos MC, Davies DC, Moss RF, Tighe D, Bennett ED. Pathophysiology of septic encephalopathy: a review. Crit Care Med. 2000;28(8):3019–24.

    Article  PubMed  CAS  Google Scholar 

  19. Licinio J, Wong M. Pathways and mechanisms for cytokine signalling of the central nervous system. J Clin Invest. 1997;100:2941–7.

    Article  PubMed  CAS  Google Scholar 

  20. Didier N, Romero IA, Creminon C, Wijkhuisen A, Grassi J, Mabondzo A. Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability. J Neurochem. 2003;86(1):246–54.

    Article  PubMed  CAS  Google Scholar 

  21. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000;32:734–9.

    Article  PubMed  CAS  Google Scholar 

  22. Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125(3): 755–64.

    Article  PubMed  Google Scholar 

  23. Jalan R, Olde Damink S, Deutz N, Lee A, Hayes P. Treatment of uncontrolled intracranial hypertension in acute liver failure with moderate hypothermia. Lancet. 1999;354:1164–8.

    Article  PubMed  CAS  Google Scholar 

  24. Jalan R, Olde Damink SW, Hayes PC, Deutz NE, Lee A. Pathogenesis of intracranial ­hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol. 2004;41(4):613–20.

    Article  PubMed  CAS  Google Scholar 

  25. Shawcross D, Wright G, Olde Damink S, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis. 2007;22:125–38.

    Article  PubMed  CAS  Google Scholar 

  26. Shawcross D, Davies N, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004;40(2):247–54.

    Article  PubMed  CAS  Google Scholar 

  27. Marini JC, Broussard SR. Hyperammonemia increases sensitivity to LPS. Mol Genet Metab. 2006;88(2):131–7.

    Article  PubMed  CAS  Google Scholar 

  28. Jover R, Rodrigo R, Felipo V, Insausti R, Saez-Valero J, Garcia-Ayllon MS, et al. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: a model of hepatic encephalopathy in cirrhosis. Hepatology. 2006;43(6):1257–66.

    Article  PubMed  CAS  Google Scholar 

  29. Wright G, Davies N, Shawcross D, Hodges S, Zwingmann C, Brooks H, et al. Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology. 2007;45(6):1517–26.

    Article  PubMed  CAS  Google Scholar 

  30. Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V. Inflammation and hepatic encephalopathy: ibuprofen restires learning ability in rats with portacaval shunts. Hepatology. 2007;46:514–9.

    Article  PubMed  CAS  Google Scholar 

  31. Clemmesen JO, Hansen BA, Larsen FS. Indomethacin normalizes intracranial pressure in acute liver failure: a twenty-three-year-old woman treated with indomethacin. Hepatology. 1997;26(6):1423–5.

    Article  PubMed  CAS  Google Scholar 

  32. Tofteng F, Larsen FS. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab. 2004;24(7):798–804.

    Article  PubMed  CAS  Google Scholar 

  33. Chung C, Gottstein J, Blei AT. Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis. Hepatology. 2001;34(2):249–54.

    Article  PubMed  CAS  Google Scholar 

  34. Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology. 2010;51(3):1062–9.

    Article  PubMed  CAS  Google Scholar 

  35. Shawcross D, Wright G, Stadlbauer V, Hodges S, Wheeler-Jones C, Pitsillides A, et al. Ammonia impairs neutrophil phagocytic function in liver disease. Hepatology. 2008;48(4):1202–12.

    Article  PubMed  CAS  Google Scholar 

  36. Haussinger D, Graf D, Weiergraber O. Glutamine and cell signaling in the liver. J Nutr. 2001;131:2509S–14.

    PubMed  CAS  Google Scholar 

  37. Jayakumar A, Panickar K, Murthy C, Norenberg M. Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J Neurosci. 2006;26(18):4774–84.

    Article  PubMed  CAS  Google Scholar 

  38. Stadlbauer V, Mookerjee R, Wright G, Davies N, Jurgens G, Hallstrom S, et al. Role of ­toll-like receptors 2, 4 and 9 in mediating neutrophils dyfunction in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol. 2009;296(1):G15–22.

    Article  PubMed  CAS  Google Scholar 

  39. Lu W, Maheshwari A, Misiuta I, Fox S, Chen N, Zigova T, et al. Neutrophil-specific chemokines are produced by astrocytic cells but not neuronal cells. Dev Brain Res. 2005;155:127–34.

    Article  CAS  Google Scholar 

  40. Bernal W, Auzinger G, Sizer E, Wendon J. Intensive care management for acute liver failure. Semin Liver Dis. 2008;28(2):188–200.

    Article  PubMed  Google Scholar 

  41. Als-Nielsen B, Gluud L, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. Br Med J. 2004;328:1046–50.

    Article  CAS  Google Scholar 

  42. Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071–81.

    Article  PubMed  CAS  Google Scholar 

  43. Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA, et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology. 2011;140(2):478–87.

    Article  PubMed  CAS  Google Scholar 

  44. Rolando N, Clapperton M, Wade J, Panetsos G, Mufti G, Williams R. Granulocyte colony-stimulating factor improves function of neutrophils from patients with acute liver failure. Eur J Gastroenterol Hepatol. 2000;12(10):1135–40.

    Article  PubMed  CAS  Google Scholar 

  45. Treacher D, Sabbato M, Brown K, Gant V. The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass. Perfusion. 2001;16:67–73.

    Article  PubMed  Google Scholar 

  46. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med. 1991;324(26):1852–7.

    Article  PubMed  CAS  Google Scholar 

  47. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39(5):1441–9.

    Article  PubMed  Google Scholar 

  48. Shawcross D, Davies N, Hodges S, Wright G, Jalan R. Hypothermia abolishes ammonia-induced neutrophil spontaneous oxidative burst [abstract]. Hepatology. 2006;44(4 Suppl 1):363A.

    Google Scholar 

  49. Jalan R, Schnurr K, Mookerjee R, Sen S, Cheshire L, Hodges S, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology. 2009;50(2):555–64.

    Article  PubMed  CAS  Google Scholar 

  50. Jiang W, Desjardins P, Butterworth R. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline. J Neurochem. 2009;109(2):485–93.

    Article  PubMed  CAS  Google Scholar 

  51. Stadlbauer V, Mookerjee R, Hodges S, Wright G, Davies N, Jalan R. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol. 2008;48(6):945–51.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Debbie Lindsay Shawcross BSc, MBBS, FRCP, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Shabbir, S.S., Seyan, A.S., Shawcross, D.L. (2012). Inflammation and Hepatic Encephalopathy. In: Mullen, K., Prakash, R. (eds) Hepatic Encephalopathy. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-836-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-836-8_4

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-835-1

  • Online ISBN: 978-1-61779-836-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics